Company: BIAF
Filing Date: 2025-04-15
Form Type: PRE 14A
Source: 0001641172-25-004857
Chunk: 66

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-15
Form: PRE 14A
Chunk 66
---
 |     |           | 611,905 |
| Jamie Platt     |     |                                 | 26,875 |     |                     | 112,498 |     |                        |       — |     |           | 139,373 |

| (1) | Amounts                                                                                                                                
 do not reflect compensation actually received by the directors. Instead, the amounts represent aggregate grant date fair value of      
 the restricted stock award computed in accordance with ASC 718, Stock Compensation. The valuation assumptions used in determining      
 such amounts are consistent with those described in Note 11 of the Company’s Consolidated Financial Statements, included elsewhere     
 in this Proxy Statement. As of December 31, 2024, the aggregate number of outstanding options, all of which are currently exercisable, 
 held by each individual who served as a non-NEO director during 2024 was as follows: Robert Anderson – 39,281; Stuart Diamond          
 – 7,142; Peter Knight – 28,568; Gary Rubin – 32,139; Roby Joyce – 0; and Jamie Platt – 0. As of December                               
 31, 2024, the aggregate number of unvested shares of restricted stock held by each non-NEO director was 8,449.                         |

| 36 |

<div align='center'>SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN BENEFICIAL OWNERS</div>

The following table sets forth information regarding the beneficial ownership of shares of the Company’s Common Stock as of April 8, 2025, by (i) each person known to the Company to beneficially own more than 5% of any class of the Company’s outstanding voting securities, (ii) each director and nominee for director, (iii) each of our named executive officers, and (iv) all of the Company’s directors and executive officers as a group.

Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60 days. In computing the number of shares beneficially owned by a person or entity and the percentage ownership of that person or entity in the table below, all shares subject to options and warrants were deemed outstanding if such securities are currently exercisable or will vest within 60 days of April 8, 2025, the Record Date. These shares were